CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk
Go back to CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk| Quest Diagnostics (NYSE: DGX) | Delayed: 238.93 +1.81 (0.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $237.12 | 52 Week High | $86.85 | |||
| Open | $235.34 | 52 Week Low | $59.66 | |||
| Day High | $240.56 | P/E | 45.00 | |||
| Day Low | $223.50 | EPS | $5.31 | |||
| Volume | 1,205,158 | |||||
| Laboratory Corp. of America Holding (NYSE: LH) | Delayed: 323.75 +0.62 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $323.13 | 52 Week High | $141.32 | |||
| Open | $319.10 | 52 Week Low | $97.79 | |||
| Day High | $325.00 | P/E | 51.80 | |||
| Day Low | $317.71 | EPS | $6.25 | |||
| Volume | 566,729 | |||||



